Nova Clinic, Russia Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2017
NCT03400722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

MEDINSERVIS LLC NOVA CLINIC | Nova Clinic, Russia

Active Ingredients

Drugs in Phase 4 Trials (3)

clomifene (clomid) (1 trial)

follitropin alfa (Gonal-F) (1 trial)

lutropin alpha (luveris) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Infertility, Female (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3